DL-6,8-THIOCTIC ACID
Chemotherapy
Ain Shams UniversitySmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Chemotherapy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
D-thioctic acid Ain Shams University | Phase 4 | BB |
TAMOXIFEN Merck Sharp & Dohme LLC | Phase 2/3 | B |
Hdepa Sun Yat-sen University | Phase 3 | B |
Ldepa Sun Yat-sen University | Phase 3 | B |
Mangafodipir Egetis Therapeutics | Phase 2 | B |
View all 13 →
Same molecule, other indications
DL-6,8-THIOCTIC ACID is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →